Aaron S. Farberg, MD

Aaron S. Farberg, MD, is a double board-certified dermatologist, Mohs surgeon, chief medical officer at Bare Dermatology in Dallas, Texas, and Dermatology Times’ editor in chief emeritus (Spring 2024).

Articles

Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

Sandra Fyfe;Dermatology Times Staff;John Strasswimmer, MD, PhD;Andrew Weinstein, MD, FAAD;Neal Bhatia, MD;Laura Ferris, MD, PhD;Aaron S. Farberg, MD

May 23rd 2023

In part 3 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Frontline Forum Part 2: Solutions in the Management and Treatment of Basal Cell Carcinoma

Sandra Fyfe;Dermatology Times Staff;John Strasswimmer, MD, PhD;Andrew Weinstein, MD, FAAD;Neal Bhatia, MD;Laura Ferris, MD, PhD;Aaron S. Farberg, MD

May 16th 2023

In part 2 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Frontline Forum Part 1: Solutions in the Management and Treatment of Basal Cell Carcinoma

Sandra Fyfe;Dermatology Times Staff;John Strasswimmer, MD, PhD;Andrew Weinstein, MD, FAAD;Neal Bhatia, MD;Laura Ferris, MD, PhD;Aaron S. Farberg, MD

May 9th 2023

In part 1 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Clinical Utilization of Cemiplimab and Future Directions

Neal Bhatia, MD;Aaron S. Farberg, MD

April 14th 2023

Experts in dermatology discuss their use cases of cemiplimab and reinforce the need for dermatologists to utilize novel and effective treatments within their patient populations.

Advances in Locally Advanced BCC Management

Neal Bhatia, MD;Aaron S. Farberg, MD

April 14th 2023

Dr Aaron Farberg discusses the role of cemiplimab in the management of BCC; highlighting the need to increase the engagement of a multidisciplinary team in the use of this treatment.

Expert Perspectives in BCC Management

Neal Bhatia, MD;Aaron S. Farberg, MD

April 14th 2023

Neal Bhatia, MD, and Aaron Farberg, MD, discuss the progression of basal carcinoma and the evolving treatment approaches to this condition.

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

Joshua Zeichner, MD;Hilary Baldwin, MD;Zoe Diana Draelos, MD;Aaron S. Farberg, MD;Leon H. Kircik, MD

March 30th 2023

In the final part of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

Joshua Zeichner, MD;Hilary Baldwin, MD;Zoe Diana Draelos, MD;Aaron S. Farberg, MD;Leon H. Kircik, MD

March 23rd 2023

In part 3 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Frontline Forum Part 2: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

Joshua Zeichner, MD;Hilary Baldwin, MD;Zoe Diana Draelos, MD;Aaron S. Farberg, MD;Leon H. Kircik, MD

March 16th 2023

In part 2 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

Joshua Zeichner, MD;Hilary Baldwin, MD;Zoe Diana Draelos, MD;Aaron S. Farberg, MD;Leon H. Kircik, MD

March 9th 2023

In part 1 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Considerations for Generic vs Brand Acne Treatment Formulations

Aaron S. Farberg, MD

January 5th 2023

An expert in acne management provide his opinion on the differences between generic vs brand acne treatments and shares his thoughts on the utilization of available isotretinoin formulations.

Overview of Acne Causes and Triggers

Aaron S. Farberg, MD

January 5th 2023

Aaron Farberg, M.D discusses some common acne causes, highlighting the role of stress, diet, and androgen receptors for this condition.

Expert Recommendations for Setting and Managing Acne Treatment Goals with Patients

Aaron S. Farberg, MD

January 5th 2023

Dr Aaron Farberg shares his recommendations for discussing acne treatment options with patients and provides insight on setting and managing patients’ goals and expectations.

<1 2